You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (15)

Journals (0)

1-10 of 15 results for elotuzumab

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Elotuzumab: Empiric analysis of dexamethasone administration schedule

Free access

Article commentary

First published 2024-1

Elotuzumab: Empiric analysis of dexamethasone administration schedule

Polly E Kintzel

Journal of Oncology Pharmacy Practice

Select article: Treatment of multiple myeloma with the immunostimulatory SLAMF7 antibody elotuzumab

Open access

Review article

First published 2016-10

Treatment of multiple myeloma with the immunostimulatory SLAMF7 antibody elotuzumab

Hermann Einsele, Martin Schreder

Therapeutic Advances in Hematology

Select article: Elotuzumab: the first approved monoclonal antibody for multiple myeloma treatment

Free access

Review article

First published 2016-8

Elotuzumab: the first approved monoclonal antibody for multiple myeloma treatment

Hila Magen, Eli Muchtar

Therapeutic Advances in Hematology

Select article: Immunotherapy

Retricted access

Review article

First published 2016-7

Immunotherapy

Salma Afifi, Angela Michael, Alexander Lesokhin

Annals of Pharmacotherapy

Select article: Alectinib,Ceritinib,Elotuzumab,and Venetoclax

Retricted access

Research article

First published 2016-7

Alectinib,Ceritinib,Elotuzumab,and Venetoclax

J. Aubrey Waddell, Dominic A. Solimando

Hospital Pharmacy

Select article: Cardiac Adverse Events Associated With Elotuzumab: A Disproportionality Analysis Using FDA Adverse Event Reporting System

Retricted access

Letter

First published 2026-4

Cardiac Adverse Events Associated With Elotuzumab: A Disproportionality Analysis Using FDA Adverse Event Reporting System

Muhammed Favas K. T, Beema T. Yoosuf, Dipika Bansal

Annals of Pharmacotherapy

Select article: Differences in safety profiles of newly approved medications for multiple myeloma in real-world settings versus randomized controlled trials

Retricted access

Research article

First published 2021-6

Differences in safety profiles of newly approved medications for multiple myeloma in real-world settings versus randomized controlled trials

Eric P Borrelli, Conor G McGladrigan

Journal of Oncology Pharmacy Practice

Select article: Multiple myeloma: Updates for pharmacists in the treatment of relapsed and refractory disease

Retricted access

Review article

First published 2016-4

Multiple myeloma: Updates for pharmacists in the treatment of relapsed and refractory disease

Emily Ashjian, Kimberly Redic

Journal of Oncology Pharmacy Practice

Select article: Patiromer

Retricted access

Review article

First published 2016-4

Patiromer

Dennis J. Cada, Jessica Dang, Danial E. Baker

Hospital Pharmacy

Select article: Using bispecific antibodies in a patient with peritoneal dialysis for relapsed multiple myeloma

Retricted access

Case report

First published 2025-10

Using bispecific antibodies in a patient with peritoneal dialysis for relapsed multiple myeloma

Heng Jiang, Yagya Ahlawat, Amir Steinberg

Journal of Oncology Pharmacy Practice

1
2
10 / page

Article type

Publication date

Subjects

Access